{"transactions":[{"id":703154,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-07-27T22:59:21.000Z","date":"2026-07-27","kind":"sale","planned":false,"acquired":false,"shares":2920.5511,"price":83.9342,"value":245134.12013762,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":8915.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-006743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006743/doc4.xml","form_type":"4"}},{"id":703153,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-07-27T22:59:21.000Z","date":"2026-07-27","kind":"gift","planned":false,"acquired":true,"shares":319.6499,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":11836.201,"source":{"system":"sec-edgar","filing":"0001225208-26-006743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006743/doc4.xml","form_type":"4"}},{"id":703152,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-07-27T22:59:21.000Z","date":"2026-07-27","kind":"gift","planned":false,"acquired":false,"shares":319.6499,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":98845,"source":{"system":"sec-edgar","filing":"0001225208-26-006743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006743/doc4.xml","form_type":"4"}},{"id":735009,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-06-18T00:19:12.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":523,"price":87.92,"value":45982.16,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025."}],"balance_after":11516.5511,"source":{"system":"sec-edgar","filing":"0001225208-26-006103","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006103/doc4.xml","form_type":"4"}},{"id":783159,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Performance Rights","published_at":"2026-05-12T20:55:45.000Z","date":"2026-05-11","kind":"exercise","planned":true,"acquired":false,"shares":47207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These Performance Rights expire on May 10, 2030."}],"balance_after":0,"derivative":{"exercise_date":"2026-05-11","underlying":"Common Stock","underlying_shares":47207},"source":{"system":"sec-edgar","filing":"0001225208-26-005172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005172/doc4.xml","form_type":"4"}},{"id":783158,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T20:55:45.000Z","date":"2026-05-12","kind":"sale","planned":true,"acquired":false,"shares":35506,"price":77.9238,"value":2766762.4428,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $77.375 to $78.360. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":12039.5511,"source":{"system":"sec-edgar","filing":"0001225208-26-005172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005172/doc4.xml","form_type":"4"}},{"id":783157,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T20:55:45.000Z","date":"2026-05-12","kind":"sale","planned":true,"acquired":false,"shares":845,"price":78.4027,"value":66250.2815,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $78.390 to $78.430. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47545.5511,"source":{"system":"sec-edgar","filing":"0001225208-26-005172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005172/doc4.xml","form_type":"4"}},{"id":783156,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T20:55:45.000Z","date":"2026-05-12","kind":"gift","planned":true,"acquired":true,"shares":26640,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":48390.5511,"source":{"system":"sec-edgar","filing":"0001225208-26-005172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005172/doc4.xml","form_type":"4"}},{"id":783155,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T20:55:45.000Z","date":"2026-05-12","kind":"gift","planned":true,"acquired":false,"shares":26640,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":99164.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-005172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005172/doc4.xml","form_type":"4"}},{"id":783154,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T20:55:45.000Z","date":"2026-05-11","kind":"tax_withholding","planned":true,"acquired":false,"shares":26198,"price":79.96,"value":2094792.08,"ownership":{"direct":true},"balance_after":125804.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-005172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005172/doc4.xml","form_type":"4"}},{"id":783153,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T20:55:45.000Z","date":"2026-05-11","kind":"exercise","planned":true,"acquired":true,"shares":47207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":157491.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-005172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005172/doc4.xml","form_type":"4"}},{"id":785468,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Performance Rights","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":43800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."}],"balance_after":43800,"derivative":{"exercise_date":"2029-05-07","underlying":"Common Stock","underlying_shares":43800},"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":785467,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":245300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":245300,"derivative":{"exercise_price":82.76,"exercise_date":"2027-05-07","expiration_date":"2033-05-06","underlying":"Common Stock","underlying_shares":245300},"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":785466,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-11","kind":"gift","planned":false,"acquired":true,"shares":5489,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":21750.5511,"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":785465,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-08","kind":"gift","planned":false,"acquired":true,"shares":4222,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":16261.5511,"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":785464,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-11","kind":"gift","planned":false,"acquired":false,"shares":5489,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":104795.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":785463,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":5398,"price":82.76,"value":446738.48,"ownership":{"direct":true},"balance_after":110284.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":785462,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-08","kind":"gift","planned":false,"acquired":false,"shares":4222,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":115682.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":785461,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":4153,"price":83.2,"value":345529.6,"ownership":{"direct":true},"balance_after":119904.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":785460,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":43800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":124057.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":792665,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-05T23:05:08.000Z","date":"2026-05-05","kind":"gift","planned":false,"acquired":true,"shares":523,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":12039.5511,"source":{"system":"sec-edgar","filing":"0001225208-26-004968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004968/doc4.xml","form_type":"4"}},{"id":792664,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-05T23:05:08.000Z","date":"2026-05-05","kind":"gift","planned":false,"acquired":false,"shares":523,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":80257.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-004968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004968/doc4.xml","form_type":"4"}},{"id":792663,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-05T23:05:08.000Z","date":"2026-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":515,"price":83.98,"value":43249.7,"ownership":{"direct":true},"balance_after":80780.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-004968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826004968/doc4.xml","form_type":"4"}},{"id":905903,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-02-13T22:37:29.000Z","date":"2026-02-12","kind":"exercise","planned":false,"acquired":false,"shares":25350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options were granted on May 8, 2019 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":0,"derivative":{"exercise_price":59.2567,"expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":25350},"source":{"system":"sec-edgar","filing":"0001225208-26-001893","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826001893/doc4.xml","form_type":"4"}},{"id":905902,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-13T22:37:29.000Z","date":"2026-02-13","kind":"gift","planned":false,"acquired":true,"shares":2920,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":11516.5511,"source":{"system":"sec-edgar","filing":"0001225208-26-001893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826001893/doc4.xml","form_type":"4"}},{"id":905901,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-13T22:37:29.000Z","date":"2026-02-13","kind":"gift","planned":false,"acquired":false,"shares":2920,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":80976,"source":{"system":"sec-edgar","filing":"0001225208-26-001893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826001893/doc4.xml","form_type":"4"}},{"id":905900,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-13T22:37:29.000Z","date":"2026-02-12","kind":"sale","planned":false,"acquired":false,"shares":19898,"price":76.6133,"value":1524451.4434,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $76.080 to $77.075 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":83896,"source":{"system":"sec-edgar","filing":"0001225208-26-001893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826001893/doc4.xml","form_type":"4"}},{"id":905899,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-13T22:37:29.000Z","date":"2026-02-12","kind":"sale","planned":false,"acquired":false,"shares":2532,"price":77.1287,"value":195289.8684,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $77.080 to $77.225 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":103794,"source":{"system":"sec-edgar","filing":"0001225208-26-001893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826001893/doc4.xml","form_type":"4"}},{"id":905898,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-13T22:37:29.000Z","date":"2026-02-12","kind":"exercise","planned":false,"acquired":true,"shares":25350,"price":59.2567,"value":1502157.345,"ownership":{"direct":true},"balance_after":106326,"source":{"system":"sec-edgar","filing":"0001225208-26-001893","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826001893/doc4.xml","form_type":"4"}},{"id":975103,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-12-10T23:58:43.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":false,"shares":25350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on May 8, 2019 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":25350,"derivative":{"exercise_price":59.2567,"expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":25350},"source":{"system":"sec-edgar","filing":"0001225208-25-009840","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009840/doc4.xml","form_type":"4"}},{"id":975102,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-12-10T23:58:43.000Z","date":"2025-12-10","kind":"sale","planned":true,"acquired":false,"shares":3863,"price":83.45,"value":322367.35,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."}],"balance_after":8596.5511,"source":{"system":"sec-edgar","filing":"0001225208-25-009840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009840/doc4.xml","form_type":"4"}},{"id":975101,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-12-10T23:58:43.000Z","date":"2025-12-09","kind":"gift","planned":true,"acquired":true,"shares":3863,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":12459.5511,"source":{"system":"sec-edgar","filing":"0001225208-25-009840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009840/doc4.xml","form_type":"4"}},{"id":975100,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-12-10T23:58:43.000Z","date":"2025-12-09","kind":"gift","planned":true,"acquired":false,"shares":3863,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":80976,"source":{"system":"sec-edgar","filing":"0001225208-25-009840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009840/doc4.xml","form_type":"4"}},{"id":975099,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-12-10T23:58:43.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":21487,"price":85.2146,"value":1831006.1102,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $84.63 to $85.57. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":84839,"source":{"system":"sec-edgar","filing":"0001225208-25-009840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009840/doc4.xml","form_type":"4"}},{"id":975098,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-12-10T23:58:43.000Z","date":"2025-12-08","kind":"exercise","planned":true,"acquired":true,"shares":25350,"price":59.2567,"value":1502157.345,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."}],"balance_after":106326,"source":{"system":"sec-edgar","filing":"0001225208-25-009840","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825009840/doc4.xml","form_type":"4"}},{"id":1126071,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-06-03T21:15:54.000Z","date":"2025-06-03","kind":"sale","planned":true,"acquired":false,"shares":967,"price":77.3232,"value":74771.5344,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $77.140 to $77.540 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":8596.5511,"source":{"system":"sec-edgar","filing":"0001225208-25-005684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825005684/doc4.xml","form_type":"4"}},{"id":1126070,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-06-03T21:15:54.000Z","date":"2025-05-30","kind":"sale","planned":true,"acquired":false,"shares":16099,"price":77.2138,"value":1243064.9662,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $76.930 to $77.585 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":9563.5511,"source":{"system":"sec-edgar","filing":"0001225208-25-005684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825005684/doc4.xml","form_type":"4"}},{"id":1146078,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-16T22:22:59.000Z","date":"2025-05-16","kind":"gift","planned":false,"acquired":true,"shares":5815.5511,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved the reporting person's transfer of 5,815.5511 shares of EW common stock directly held to the reporting person's Family Trust for no consideration."}],"balance_after":25662.5511,"source":{"system":"sec-edgar","filing":"0001225208-25-005233","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825005233/doc4.xml","form_type":"4"}},{"id":1146077,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-16T22:22:59.000Z","date":"2025-05-16","kind":"gift","planned":false,"acquired":false,"shares":5815.5511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction involved the reporting person's transfer of 5,815.5511 shares of EW common stock directly held to the reporting person's Family Trust for no consideration."}],"balance_after":80976,"source":{"system":"sec-edgar","filing":"0001225208-25-005233","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825005233/doc4.xml","form_type":"4"}},{"id":1151339,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-13T21:16:17.000Z","date":"2025-05-13","kind":"gift","planned":false,"acquired":true,"shares":2771,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":19847,"source":{"system":"sec-edgar","filing":"0001225208-25-005052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825005052/doc4.xml","form_type":"4"}},{"id":1151338,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-13T21:16:17.000Z","date":"2025-05-13","kind":"gift","planned":false,"acquired":false,"shares":2771,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":86791.5511,"source":{"system":"sec-edgar","filing":"0001225208-25-005052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825005052/doc4.xml","form_type":"4"}},{"id":1151337,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-13T21:16:17.000Z","date":"2025-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2860,"price":73.68,"value":210724.8,"ownership":{"direct":true},"balance_after":89562.5511,"source":{"system":"sec-edgar","filing":"0001225208-25-005052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825005052/doc4.xml","form_type":"4"}},{"id":1154298,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Performance Rights","published_at":"2025-05-09T23:34:11.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":43550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":43550,"derivative":{"exercise_date":"2028-05-08","underlying":"Common Stock","underlying_shares":43550},"source":{"system":"sec-edgar","filing":"0001225208-25-004941","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004941/doc4.xml","form_type":"4"}},{"id":1154297,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-05-09T23:34:11.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":244400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":244400,"derivative":{"exercise_price":74.63,"exercise_date":"2026-05-08","expiration_date":"2032-05-07","underlying":"Common Stock","underlying_shares":244400},"source":{"system":"sec-edgar","filing":"0001225208-25-004941","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004941/doc4.xml","form_type":"4"}},{"id":1154296,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-09T23:34:11.000Z","date":"2025-05-08","kind":"gift","planned":false,"acquired":true,"shares":4122,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":17076,"source":{"system":"sec-edgar","filing":"0001225208-25-004941","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004941/doc4.xml","form_type":"4"}},{"id":1154295,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-09T23:34:11.000Z","date":"2025-05-08","kind":"gift","planned":false,"acquired":false,"shares":4122,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":92422.5511,"source":{"system":"sec-edgar","filing":"0001225208-25-004941","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004941/doc4.xml","form_type":"4"}},{"id":1154294,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-09T23:34:11.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":43550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":96544.5511,"source":{"system":"sec-edgar","filing":"0001225208-25-004941","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004941/doc4.xml","form_type":"4"}},{"id":1154293,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-09T23:34:11.000Z","date":"2025-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":4253,"price":74.92,"value":318634.76,"ownership":{"direct":true},"balance_after":52994.5511,"source":{"system":"sec-edgar","filing":"0001225208-25-004941","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004941/doc4.xml","form_type":"4"}},{"id":1157768,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-05-06T21:13:15.000Z","date":"2025-05-05","kind":"exercise","planned":true,"acquired":false,"shares":7462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on May 17, 2018 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one yearafter the grant date in four equal annual installments."}],"balance_after":0,"derivative":{"exercise_price":45.2767,"expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":7462},"source":{"system":"sec-edgar","filing":"0001225208-25-004799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004799/doc4.xml","form_type":"4"}},{"id":1157767,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-06T21:13:15.000Z","date":"2025-05-06","kind":"gift","planned":true,"acquired":true,"shares":1036,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":12954,"source":{"system":"sec-edgar","filing":"0001225208-25-004799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004799/doc4.xml","form_type":"4"}},{"id":1157766,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-06T21:13:15.000Z","date":"2025-05-05","kind":"gift","planned":true,"acquired":true,"shares":1482,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":11918,"source":{"system":"sec-edgar","filing":"0001225208-25-004799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004799/doc4.xml","form_type":"4"}},{"id":1157765,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-06T21:13:15.000Z","date":"2025-05-06","kind":"gift","planned":true,"acquired":false,"shares":1036,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":57247.5511,"source":{"system":"sec-edgar","filing":"0001225208-25-004799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004799/doc4.xml","form_type":"4"}},{"id":1157764,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-06T21:13:15.000Z","date":"2025-05-05","kind":"sale","planned":true,"acquired":false,"shares":5980,"price":74.9125,"value":447976.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $74.67 to $75.15 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":58283.5511,"source":{"system":"sec-edgar","filing":"0001225208-25-004799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004799/doc4.xml","form_type":"4"}},{"id":1157763,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-06T21:13:15.000Z","date":"2025-05-05","kind":"gift","planned":true,"acquired":false,"shares":1482,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":64263.5511,"source":{"system":"sec-edgar","filing":"0001225208-25-004799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004799/doc4.xml","form_type":"4"}},{"id":1157762,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-06T21:13:15.000Z","date":"2025-05-05","kind":"exercise","planned":true,"acquired":true,"shares":7462,"price":45.2767,"value":337854.7354,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024."}],"balance_after":65745.5511,"source":{"system":"sec-edgar","filing":"0001225208-25-004799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004799/doc4.xml","form_type":"4"}},{"id":1157761,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-06T21:13:15.000Z","date":"2025-05-04","kind":"tax_withholding","planned":true,"acquired":false,"shares":543,"price":75.65,"value":41077.95,"ownership":{"direct":true},"balance_after":58283.5511,"source":{"system":"sec-edgar","filing":"0001225208-25-004799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004799/doc4.xml","form_type":"4"}},{"id":1157760,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-05-06T21:13:15.000Z","date":"2025-05-03","kind":"tax_withholding","planned":true,"acquired":false,"shares":527,"price":75.65,"value":39867.55,"ownership":{"direct":true},"balance_after":58826.5511,"source":{"system":"sec-edgar","filing":"0001225208-25-004799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825004799/doc4.xml","form_type":"4"}},{"id":1215849,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2025-03-10T23:35:10.000Z","date":"2025-03-10","kind":"exercise","planned":true,"acquired":false,"shares":7463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options were granted on May 17, 2018 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one yearafter the grant date in four equal annual installments."}],"balance_after":7462,"derivative":{"exercise_price":45.2767,"expiration_date":"2025-05-16","underlying":"Common Stock","underlying_shares":7463},"source":{"system":"sec-edgar","filing":"0001225208-25-003195","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825003195/doc4.xml","form_type":"4"}},{"id":1215848,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-03-10T23:35:10.000Z","date":"2025-03-10","kind":"gift","planned":true,"acquired":true,"shares":1299,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":10436,"source":{"system":"sec-edgar","filing":"0001225208-25-003195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825003195/doc4.xml","form_type":"4"}},{"id":1215847,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-03-10T23:35:10.000Z","date":"2025-03-10","kind":"sale","planned":true,"acquired":false,"shares":6164,"price":69.5081,"value":428447.9284,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $69.41 to $69.64 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":59082.9006,"source":{"system":"sec-edgar","filing":"0001225208-25-003195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825003195/doc4.xml","form_type":"4"}},{"id":1215846,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-03-10T23:35:10.000Z","date":"2025-03-10","kind":"gift","planned":true,"acquired":false,"shares":1299,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":65246.9006,"source":{"system":"sec-edgar","filing":"0001225208-25-003195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825003195/doc4.xml","form_type":"4"}},{"id":1215845,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-03-10T23:35:10.000Z","date":"2025-03-10","kind":"exercise","planned":true,"acquired":true,"shares":7463,"price":45.2767,"value":337900.0121,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024."}],"balance_after":66545.9006,"source":{"system":"sec-edgar","filing":"0001225208-25-003195","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520825003195/doc4.xml","form_type":"4"}},{"id":1498371,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-05-30T21:10:49.000Z","date":"2024-05-30","kind":"sale","planned":true,"acquired":false,"shares":8617,"price":87.68,"value":755538.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 29, 2024."}],"balance_after":68217.9005,"source":{"system":"sec-edgar","filing":"0001225208-24-006448","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824006448/doc4.xml","form_type":"4"}},{"id":1519588,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-05-13T21:45:46.000Z","date":"2024-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2854,"price":86.72,"value":247498.88,"ownership":{"direct":true},"balance_after":76834.9005,"source":{"system":"sec-edgar","filing":"0001225208-24-005979","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005979/doc4.xml","form_type":"4"}},{"id":1522386,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Performance Rights","published_at":"2024-05-09T23:38:08.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":33500,"derivative":{"exercise_date":"2027-05-07","underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0001225208-24-005886","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005886/doc4.xml","form_type":"4"}},{"id":1522385,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2024-05-09T23:38:08.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":178400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":178400,"derivative":{"exercise_price":85.84,"exercise_date":"2025-05-07","expiration_date":"2031-05-06","underlying":"Common Stock","underlying_shares":178400},"source":{"system":"sec-edgar","filing":"0001225208-24-005886","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005886/doc4.xml","form_type":"4"}},{"id":1522384,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-05-09T23:38:08.000Z","date":"2024-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":647,"price":85.09,"value":55053.23,"ownership":{"direct":true},"balance_after":79688.9005,"source":{"system":"sec-edgar","filing":"0001225208-24-005886","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005886/doc4.xml","form_type":"4"}},{"id":1522383,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-05-09T23:38:08.000Z","date":"2024-05-07","kind":"grant","planned":false,"acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":80335.9005,"source":{"system":"sec-edgar","filing":"0001225208-24-005886","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005886/doc4.xml","form_type":"4"}},{"id":1525140,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Performance Rights","published_at":"2024-05-07T21:53:27.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":false,"shares":6265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2024-05-04","underlying":"Common Stock","underlying_shares":6265},"source":{"system":"sec-edgar","filing":"0001225208-24-005743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005743/doc4.xml","form_type":"4"}},{"id":1525139,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-05-07T21:53:27.000Z","date":"2024-05-06","kind":"purchase","planned":false,"acquired":true,"shares":580.2601,"price":85.7421,"value":49752.71952021,"ownership":{"direct":false,"nature":"401(k)"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator."}],"balance_after":3267.6552,"source":{"system":"sec-edgar","filing":"0001225208-24-005743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005743/doc4.xml","form_type":"4"}},{"id":1525138,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-05-07T21:53:27.000Z","date":"2024-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":3718,"price":85.25,"value":316959.5,"ownership":{"direct":true},"balance_after":46835.9005,"source":{"system":"sec-edgar","filing":"0001225208-24-005743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005743/doc4.xml","form_type":"4"}},{"id":1525137,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-05-07T21:53:27.000Z","date":"2024-05-04","kind":"exercise","planned":false,"acquired":true,"shares":6265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":50553.9005,"source":{"system":"sec-edgar","filing":"0001225208-24-005743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005743/doc4.xml","form_type":"4"}},{"id":1525136,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-05-07T21:53:27.000Z","date":"2024-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":527,"price":85.06,"value":44826.62,"ownership":{"direct":true},"balance_after":44288.9005,"source":{"system":"sec-edgar","filing":"0001225208-24-005743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520824005743/doc4.xml","form_type":"4"}},{"id":1819517,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-08-01T22:33:22.000Z","date":"2023-07-31","kind":"other","planned":false,"acquired":true,"shares":2558.6207,"price":83.5389,"value":213744.35879523,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The exact unit price to its last decimal number is $83.538983."}],"balance_after":47111.4942,"source":{"system":"sec-edgar","filing":"0001225208-23-007850","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823007850/doc4.xml","form_type":"4"}},{"id":1894036,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Performance Rights","published_at":"2023-05-15T22:25:52.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":28150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 11, 2026. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 11, 2026. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":28150,"derivative":{"exercise_date":"2026-05-11","underlying":"Common Stock","underlying_shares":28150},"source":{"system":"sec-edgar","filing":"0001225208-23-005916","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005916/doc4.xml","form_type":"4"}},{"id":1894035,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2023-05-15T22:25:52.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":173700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":173700,"derivative":{"exercise_price":88.78,"exercise_date":"2024-05-11","expiration_date":"2030-05-10","underlying":"Common Stock","underlying_shares":173700},"source":{"system":"sec-edgar","filing":"0001225208-23-005916","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005916/doc4.xml","form_type":"4"}},{"id":1894034,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-05-15T22:25:52.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":22525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":44552.8735,"source":{"system":"sec-edgar","filing":"0001225208-23-005916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005916/doc4.xml","form_type":"4"}},{"id":1899931,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Performance Rights","published_at":"2023-05-10T00:53:29.000Z","date":"2023-05-07","kind":"exercise","planned":false,"acquired":false,"shares":5003,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 7, 2020, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2023, the Compensation Committee of the Board of Directors determined that 78.48% of the target number of shares would vest as of May 1, 2023, and the actual number of shares vested are reflected on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 7, 2020, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2023, the Compensation Committee of the Board of Directors determined that 78.48% of the target number of shares would vest as of May 1, 2023, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":1372,"derivative":{"exercise_price":0,"exercise_date":"2023-05-07","underlying":"Common Stock","underlying_shares":5003},"source":{"system":"sec-edgar","filing":"0001225208-23-005622","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005622/doc4.xml","form_type":"4"}},{"id":1899930,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-05-10T00:53:29.000Z","date":"2023-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1433,"price":88.74,"value":127164.42,"ownership":{"direct":true},"balance_after":22027.8735,"source":{"system":"sec-edgar","filing":"0001225208-23-005622","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005622/doc4.xml","form_type":"4"}},{"id":1899929,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-05-10T00:53:29.000Z","date":"2023-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":2323,"price":88.74,"value":206143.02,"ownership":{"direct":true},"balance_after":23460.8735,"source":{"system":"sec-edgar","filing":"0001225208-23-005622","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005622/doc4.xml","form_type":"4"}},{"id":1899928,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-05-10T00:53:29.000Z","date":"2023-05-07","kind":"exercise","planned":false,"acquired":true,"shares":5003,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 7, 2020, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2023, the Compensation Committee of the Board of Directors determined that 78.48% of the target number of shares would vest as of May 1, 2023, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 7, 2020, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2023, the Compensation Committee of the Board of Directors determined that 78.48% of the target number of shares would vest as of May 1, 2023, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":25783.8735,"source":{"system":"sec-edgar","filing":"0001225208-23-005622","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005622/doc4.xml","form_type":"4"}},{"id":1904803,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-05-05T01:50:51.000Z","date":"2023-05-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":370,"price":88.1,"value":32597.0,"ownership":{"direct":true},"balance_after":20780.8735,"source":{"system":"sec-edgar","filing":"0001225208-23-005437","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005437/doc4.xml","form_type":"4"}},{"id":1904802,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"President"}}],"security":"Common Stock","published_at":"2023-05-05T01:50:51.000Z","date":"2023-05-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":359,"price":87.81,"value":31523.79,"ownership":{"direct":true},"balance_after":21150.8735,"source":{"system":"sec-edgar","filing":"0001225208-23-005437","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520823005437/doc4.xml","form_type":"4"}},{"id":2193751,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2022-08-05T22:05:28.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":4811,"price":103.66,"value":498708.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2021."}],"balance_after":21246.9647,"source":{"system":"sec-edgar","filing":"0001225208-22-009330","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822009330/doc4.xml","form_type":"4"}},{"id":2233127,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2022-06-14T23:43:56.000Z","date":"2022-06-14","kind":"sale","acquired":false,"shares":4809,"price":87.75,"value":421989.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2021."}],"balance_after":26007.7011,"source":{"system":"sec-edgar","filing":"0001225208-22-008104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822008104/doc4.xml","form_type":"4"}},{"id":2251964,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2022-05-31T22:35:01.000Z","date":"2022-05-31","kind":"sale","acquired":false,"shares":9000,"price":100.8321,"value":907488.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $100.83 to $100.85. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":30816,"source":{"system":"sec-edgar","filing":"0001225208-22-007468","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822007468/doc4.xml","form_type":"4"}},{"id":2258758,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2022-05-24T23:41:09.000Z","date":"2022-05-24","kind":"sale","acquired":false,"shares":4809,"price":95.52,"value":459355.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2021."}],"balance_after":39816,"source":{"system":"sec-edgar","filing":"0001225208-22-007372","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822007372/doc4.xml","form_type":"4"}},{"id":2268871,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2022-05-18T01:16:45.000Z","date":"2022-05-17","kind":"tax_withholding","acquired":false,"shares":1711,"price":95.93,"value":164136.23,"ownership":{"direct":true},"balance_after":44625,"source":{"system":"sec-edgar","filing":"0001225208-22-007140","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822007140/doc4.xml","form_type":"4"}},{"id":2276630,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Performance Rights","published_at":"2022-05-11T01:05:04.000Z","date":"2022-05-08","kind":"exercise","acquired":false,"shares":12600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2022-05-08","underlying":"Common Stock","underlying_shares":12600},"source":{"system":"sec-edgar","filing":"0001225208-22-006819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006819/doc4.xml","form_type":"4"}},{"id":2276629,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2022-05-11T01:05:04.000Z","date":"2022-05-08","kind":"tax_withholding","acquired":false,"shares":6837,"price":100.52,"value":687255.24,"ownership":{"direct":true},"balance_after":46336,"source":{"system":"sec-edgar","filing":"0001225208-22-006819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006819/doc4.xml","form_type":"4"}},{"id":2276628,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2022-05-11T01:05:04.000Z","date":"2022-05-08","kind":"exercise","acquired":true,"shares":12600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 8, 2019, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 2, 2022, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 8, 2022, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":53173,"source":{"system":"sec-edgar","filing":"0001225208-22-006819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006819/doc4.xml","form_type":"4"}},{"id":2276627,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2022-05-11T01:05:04.000Z","date":"2022-05-07","kind":"tax_withholding","acquired":false,"shares":633,"price":100.52,"value":63629.16,"ownership":{"direct":true},"balance_after":40573,"source":{"system":"sec-edgar","filing":"0001225208-22-006819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006819/doc4.xml","form_type":"4"}},{"id":2281174,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Performance Rights","published_at":"2022-05-05T21:52:54.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 3, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 3, 2025. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 3, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 3, 2025. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards."}],"balance_after":5200,"derivative":{"exercise_date":"2025-05-03","underlying":"Common Stock","underlying_shares":5200},"source":{"system":"sec-edgar","filing":"0001225208-22-006585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006585/doc4.xml","form_type":"4"}},{"id":2281173,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2022-05-05T21:52:54.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":33700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 3, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":33700,"derivative":{"exercise_price":105.93,"exercise_date":"2023-05-03","expiration_date":"2029-05-02","underlying":"Common Stock","underlying_shares":33700},"source":{"system":"sec-edgar","filing":"0001225208-22-006585","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006585/doc4.xml","form_type":"4"}},{"id":2281172,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2022-05-05T21:52:54.000Z","date":"2022-05-04","kind":"tax_withholding","acquired":false,"shares":370,"price":105.93,"value":39194.1,"ownership":{"direct":true},"balance_after":41206,"source":{"system":"sec-edgar","filing":"0001225208-22-006585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006585/doc4.xml","form_type":"4"}},{"id":2281171,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2022-05-05T21:52:54.000Z","date":"2022-05-03","kind":"grant","acquired":true,"shares":4150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 3, 2022 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":41576,"source":{"system":"sec-edgar","filing":"0001225208-22-006585","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520822006585/doc4.xml","form_type":"4"}},{"id":4041342,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"CVP, TMTT"}}],"security":"Common Stock","published_at":"2018-02-22T23:24:53.000Z","date":"2018-02-20","kind":"tax_withholding","acquired":false,"shares":546,"price":133.82,"value":73065.72,"ownership":{"direct":true},"balance_after":12588.775,"source":{"system":"sec-edgar","filing":"0001225208-18-003866","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520818003866/doc4.xml","form_type":"4"}},{"id":4158800,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"CVP, Surgical Heart Valves"}}],"security":"Common Stock","published_at":"2017-11-17T22:25:48.000Z","date":"2017-11-16","kind":"grant","acquired":true,"shares":934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on November 16, 2017 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become 50% vested three years after the grant date and 50% vested four years after the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator"}],"balance_after":13134.775,"source":{"system":"sec-edgar","filing":"0001225208-17-017472","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817017472/doc4.xml","form_type":"4"}},{"id":4321426,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"CVP, Surgical Heart Valves"}}],"security":"Performance Rights","published_at":"2017-05-15T21:18:45.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":3175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 11, 2017 and scheduled to vest on May 11, 2020. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Award."},{"field":"shares","element":"transactionShares","label":"F4","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 11, 2017 and scheduled to vest on May 11, 2020. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 11, 2017 and scheduled to vest on May 11, 2020. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 11, 2017 and scheduled to vest on May 11, 2020. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Award."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program on May 11, 2017 and scheduled to vest on May 11, 2020. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."}],"balance_after":3175,"derivative":{"exercise_date":"2020-05-11","underlying":"Common Stock","underlying_shares":3175},"source":{"system":"sec-edgar","filing":"0001225208-17-009777","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817009777/doc4.xml","form_type":"4"}},{"id":4321425,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"officer":true,"officer_title":"CVP, Surgical Heart Valves"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2017-05-15T21:18:45.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":22400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on May 11, 2017 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person."}],"balance_after":22400,"derivative":{"exercise_price":110.25,"exercise_date":"2018-05-11","expiration_date":"2024-05-10","underlying":"Common Stock","underlying_shares":22400},"source":{"system":"sec-edgar","filing":"0001225208-17-009777","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520817009777/doc4.xml","form_type":"4"}}],"next_cursor":"2017-05-15T21:18:45.000000Z,4321425"}